The Total Lab Automation Market is experiencing significant expansion as laboratories increasingly adopt automated technologies to improve operational efficiency, accuracy, productivity, and workflow consistency. The market size is expected to reach US$ 31.47 billion by 2034, increasing from US$ 15.27 billion in 2025. The market is estimated to register a CAGR of 8.37% from 2026 to 2034....
The global Injectable Drug Delivery Market is witnessing steady expansion as injectable therapies become increasingly important across chronic diseases, acute conditions, and emergency care. The market size is projected to reach 84.08 billion by 2031 from 48.89 billion in 2024, registering a CAGR of 8.2% during 2025–2031. The growth reflects increasing demand for injectable therapies, the...
The global Hematology Analyzers market is witnessing steady growth, driven by the increasing importance of blood analysis and diagnostic testing in healthcare. The market was valued at US$ 4.76 billion in 2025 and is projected to reach US$ 8.09 billion by 2034, registering a compound annual growth rate (CAGR) of 6.07% during 2026–2034. This expansion highlights the growing market...
The Global Hematocrit Centrifuges Market is witnessing steady expansion due to increasing demand for accurate blood analysis, rising diagnostic testing volumes, and advancements in laboratory technologies. Hematocrit centrifuges are specialized laboratory instruments used to determine the proportion of red blood cells in a blood sample. These devices operate through centrifugal force,...
Sickle cell disease is a hereditary blood disorder characterized by the production of abnormal hemoglobin, leading to distorted red blood cells that can obstruct blood flow and cause severe complications. The condition affects millions of individuals globally and often requires lifelong management. Growing awareness of genetic disorders, advancements in treatment options, and increasing...
Valued at USD 2.5 billion in 2024, the apheresis equipment market is projected to reach USD 2.68 billion in 2025 and USD 5 billion by 2034, growing at a CAGR of 7.00% during the forecast period 2025–2034. Medical technology advances, a rising chronic disease burden and growing demand for blood components are lifting procedure volumes, while innovation in procedures and separation...
Polaris Market Research today announced findings from its latest report, projecting the global plasma protease C1-inhibitor market to grow from USD 3.51 billion in 2023 to USD 7.96 billion by 2032, at a CAGR of 9.6% from 2024 to 2032. The report profiles 10 leading companies across three market segments and five regions, with detailed market size, market share and market forecast analysis....
"
According to the latest report published by Data Bridge Market Research, the Apheresis Market
CAGR Value
The global Apheresis market size was valued at USD 2.20 billion in 2025 and is expected to reach USD 4.36 billion by 2033, at a CAGR of 8.95% during the forecast period
A talented team works strictly with their potential...
According to a new report by Polaris Market Research, the global veterinary clinical chemistry diagnostics market was valued at USD 2.58 billion in 2025 and is projected to reach USD 5.39 billion by 2034, expanding at a CAGR of 8.55% over the forecast period. Growth is underpinned by rising pet adoption and healthcare expenditure, coupled with government initiatives for livestock...
According to a new report by Polaris Market Research, the global coagulation analyzer market was valued at USD 4.42 billion in 2025 and is projected to reach USD 6.81 billion by 2034, expanding at a CAGR of 4.9% over the forecast period. Growth is underpinned by rising prevalence of blood-clotting disorders, expanding cardiovascular disease burden, and accelerating adoption of...
According to a new report by Polaris Market Research, the global coagulation analyzer market was valued at USD 4.42 billion in 2025 and is projected to reach USD 6.81 billion by 2034, expanding at a CAGR of 4.9% over the forecast period. Growth is underpinned by rising prevalence of blood-clotting disorders, expanding cardiovascular disease burden, and accelerating adoption of...
Acute Myeloid Leukaemia Therapeutics Market
The Acute Myeloid Leukaemia Therapeutics Market is expanding as pharmaceutical companies, researchers, and healthcare providers increasingly focus on improving outcomes for patients affected by acute myeloid leukemia (AML), an aggressive hematological malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone...
